• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过多组学数据整合对结直肠癌中的[具体内容]和hsa-miR-137进行全面探索。 (注:原文中“Holistic exploration of and”这里“of”后面似乎缺失了关键信息)

Holistic exploration of and hsa-miR-137 in colorectal cancer via multi-omic data Integration.

作者信息

Safarpour Hossein, Ranjbaran Javad, Erfanian Nafiseh, Nomiri Samira, Derakhshani Afshin, Gerarduzzi Casimiro, Miraki Feriz Adib, HosseiniGol Edris, Saghafi Samira, Silvestris Nicola

机构信息

Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran.

Department of Clinical Biochemistry, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.

出版信息

Heliyon. 2024 Mar 3;10(5):e27046. doi: 10.1016/j.heliyon.2024.e27046. eCollection 2024 Mar 15.

DOI:10.1016/j.heliyon.2024.e27046
PMID:38495181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10943347/
Abstract

Colorectal cancer (CRC) ranks among the most widespread malignancies globally, with early detection significantly influencing prognosis. Employing a systems biology approach, we aimed to unravel the intricate mRNA-miRNA network linked to CRC pathogenesis, potentially yielding diagnostic biomarkers. Through an integrative analysis of microarray, Bulk RNA-seq, and single-cell RNA-seq data, we explored CRC-related transcriptomes comprehensively. Differential gene expression analysis uncovered crucial genes, while Weighted Gene Co-expression Network Analysis (WGCNA) identified key modules closely linked to CRC. Remarkably, CRC manifested its strongest correlation with the turquoise module, signifying its pivotal role. From the cohort of genes showing high Gene Significance (GS) and Module Membership (MM), and Differential Expression Genes (DEGs), we highlighted the downregulated Chromogranin A () as a notable hub gene in CRC. This finding was corroborated by the Human Protein Atlas database, which illustrated decreased expression in CRC tissues. Additionally, displayed elevated expression in primary versus metastatic cell lines, as evidenced by the CCLE database. Subsequent RT-qPCR validation substantiated the marked downregulation of in CRC tissues, reinforcing the significance of our differential expression analysis. Analyzing the Space-Time Gut Cell Atlas dataset underscored specific expression in epithelial cell subclusters, a trend persisting across developmental stages. Furthermore, our scrutiny of colon and small intestine Enteroendocrine cells uncovered distinct expression patterns, accentuating its role in CRC pathogenesis. Utilizing the WGCNA algorithm and TargetScan database, we validated the downregulation of hsa-miR-137 in CRC, and integrated assessment highlighted its interplay with . Our findings advocate hsa-miR-137 and as promising CRC biomarkers, offering valuable insights into diagnosis and prognosis. Despite proteomic analysis yielding no direct correlation, our multifaceted approach contributes comprehensive understanding of CRC's intricate regulatory mechanisms. In conclusion, this study advances hsa-miR-137 and as promising CRC biomarkers through an integrated analysis of diverse datasets and network interactions.

摘要

结直肠癌(CRC)是全球最常见的恶性肿瘤之一,早期检测对预后有重大影响。我们采用系统生物学方法,旨在揭示与CRC发病机制相关的复杂mRNA-miRNA网络,有望发现诊断生物标志物。通过对微阵列、批量RNA测序和单细胞RNA测序数据的综合分析,我们全面探索了与CRC相关的转录组。差异基因表达分析发现了关键基因,而加权基因共表达网络分析(WGCNA)确定了与CRC密切相关的关键模块。值得注意的是,CRC与绿松石模块的相关性最强,表明其关键作用。在显示高基因显著性(GS)、模块成员资格(MM)和差异表达基因(DEG)的基因队列中,我们强调了下调的嗜铬粒蛋白A()是CRC中一个显著的枢纽基因。人类蛋白质图谱数据库证实了这一发现,该数据库显示CRC组织中的表达降低。此外,CCLE数据库证明,在原发性与转移性细胞系中,表达升高。随后的RT-qPCR验证证实了CRC组织中显著下调,加强了我们差异表达分析的重要性。对时空肠道细胞图谱数据集的分析强调了在上皮细胞亚群中的特定表达,这一趋势在发育阶段持续存在。此外,我们对结肠和小肠肠内分泌细胞的研究发现了不同的表达模式,突出了其在CRC发病机制中的作用。利用WGCNA算法和TargetScan数据库,我们验证了CRC中hsa-miR-137的下调,综合评估突出了其与的相互作用。我们的研究结果表明hsa-miR-137和是有前景的CRC生物标志物,为诊断和预后提供了有价值的见解。尽管蛋白质组学分析未发现直接相关性,但我们的多方面方法有助于全面了解CRC复杂的调控机制。总之,本研究通过对不同数据集和网络相互作用的综合分析,将hsa-miR-137和推进为有前景的CRC生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2576/10943347/a9b8ebf6da35/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2576/10943347/141cc8cee480/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2576/10943347/b4b92448c1ac/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2576/10943347/b72899745d9b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2576/10943347/a9b8ebf6da35/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2576/10943347/141cc8cee480/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2576/10943347/b4b92448c1ac/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2576/10943347/b72899745d9b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2576/10943347/a9b8ebf6da35/gr4.jpg

相似文献

1
Holistic exploration of and hsa-miR-137 in colorectal cancer via multi-omic data Integration.通过多组学数据整合对结直肠癌中的[具体内容]和hsa-miR-137进行全面探索。 (注:原文中“Holistic exploration of and”这里“of”后面似乎缺失了关键信息)
Heliyon. 2024 Mar 3;10(5):e27046. doi: 10.1016/j.heliyon.2024.e27046. eCollection 2024 Mar 15.
2
Experimental validation of in silico analysis estimated the reverse effect of upregulated hsa-miR-106a-5p and hsa-miR-223-3p on SLC4A4 gene expression in Iranian patients with colorectal adenocarcinoma by RT-qPCR.通过 RT-qPCR 实验验证了伊朗结直肠腺癌患者中上调的 hsa-miR-106a-5p 和 hsa-miR-223-3p 对 SLC4A4 基因表达的反式作用的计算机分析预测。
Cancer Med. 2023 Mar;12(6):7005-7018. doi: 10.1002/cam4.5499. Epub 2022 Dec 5.
3
Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.综合分析确定微小RNA-195是结直肠癌中Hippo-YAP信号通路的抑制因子。
J Hematol Oncol. 2017 Mar 29;10(1):79. doi: 10.1186/s13045-017-0445-8.
4
Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis.通过加权基因共表达网络分析鉴定与结肠癌病理分期相关的miRNA和基因模块。
Onco Targets Ther. 2018 May 15;11:2815-2830. doi: 10.2147/OTT.S163891. eCollection 2018.
5
The integrative multi-omics approach identifies the novel competing endogenous RNA (ceRNA) network in colorectal cancer.综合多组学方法鉴定结直肠癌中新型竞争性内源 RNA (ceRNA) 网络。
Sci Rep. 2023 Nov 9;13(1):19454. doi: 10.1038/s41598-023-46620-z.
6
Identification of key genes in colorectal cancer diagnosis by co-expression analysis weighted gene co-expression network analysis.通过共表达分析加权基因共表达网络分析鉴定结直肠癌诊断中的关键基因。
Comput Biol Med. 2023 May;157:106779. doi: 10.1016/j.compbiomed.2023.106779. Epub 2023 Mar 11.
7
Identification of Hub Genes for Colorectal Cancer with Liver Metastasis Using miRNA-mRNA Network.基于 miRNA-mRNA 网络的结直肠癌肝转移的枢纽基因鉴定。
Dis Markers. 2023 Feb 7;2023:2295788. doi: 10.1155/2023/2295788. eCollection 2023.
8
The New Role of Signaling Axis in Colorectal Cancer.信号轴在结直肠癌中的新作用。
Front Biosci (Landmark Ed). 2023 Nov 24;28(11):301. doi: 10.31083/j.fbl2811301.
9
Identification of novel biomarkers affecting the metastasis of colorectal cancer through bioinformatics analysis and validation through qRT-PCR.通过生物信息学分析鉴定影响结直肠癌转移的新型生物标志物,并通过qRT-PCR进行验证。
Cancer Cell Int. 2020 Mar 30;20:105. doi: 10.1186/s12935-020-01180-4. eCollection 2020.
10
Identification of Hub Genes Associated with Hypertension and Their Interaction with miRNA Based on Weighted Gene Coexpression Network Analysis (WGCNA) Analysis.基于加权基因共表达网络分析(WGCNA)的高血压相关枢纽基因鉴定及其与 miRNA 的相互作用。
Med Sci Monit. 2020 Sep 5;26:e923514. doi: 10.12659/MSM.923514.

引用本文的文献

1
Characterizing Duodenal Immune Microenvironment in Functional Dyspepsia: An AutoML-Driven Diagnostic Framework.功能性消化不良中十二指肠免疫微环境的特征分析:一种自动机器学习驱动的诊断框架
J Inflamm Res. 2025 Jul 15;18:9201-9227. doi: 10.2147/JIR.S524791. eCollection 2025.

本文引用的文献

1
Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN.2020年和2040年全球结直肠癌负担:来自全球癌症负担(GLOBOCAN)的发病率和死亡率估计
Gut. 2023 Feb;72(2):338-344. doi: 10.1136/gutjnl-2022-327736. Epub 2022 Sep 8.
2
Prediction and validation of GUCA2B as the hub-gene in colorectal cancer based on co-expression network analysis: In-silico and in-vivo study.基于共表达网络分析预测和验证 GUCA2B 作为结直肠癌的枢纽基因:计算机模拟和体内研究。
Biomed Pharmacother. 2022 Mar;147:112691. doi: 10.1016/j.biopha.2022.112691. Epub 2022 Feb 9.
3
Novel Diagnostic Biomarkers in Colorectal Cancer.
结直肠癌中的新型诊断生物标志物
Int J Mol Sci. 2022 Jan 13;23(2):852. doi: 10.3390/ijms23020852.
4
Identification of early diagnostic biomarkers via WGCNA in gastric cancer.通过 WGCNA 鉴定胃癌的早期诊断生物标志物。
Biomed Pharmacother. 2022 Jan;145:112477. doi: 10.1016/j.biopha.2021.112477. Epub 2021 Dec 2.
5
The impact of recent next generation sequencing and the need for a new classification in gastric cancer.近期下一代测序技术的影响以及胃癌新分类的必要性。
Best Pract Res Clin Gastroenterol. 2021 Mar-Apr;50-51:101730. doi: 10.1016/j.bpg.2021.101730. Epub 2021 Feb 15.
6
Histopathological Chromogranin A-Positivity Is Associated with Right-Sided Colorectal Cancers and Worse Prognosis.组织病理学嗜铬粒蛋白A阳性与右半结肠癌及较差预后相关。
Cancers (Basel). 2020 Dec 29;13(1):67. doi: 10.3390/cancers13010067.
7
Chromogranin Serves as Novel Biomarker of Endocrine and Gastric Autoimmunity.嗜铬粒蛋白作为内分泌和胃自身免疫的新型生物标志物。
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa288.
8
Colon Cancer: A Clinician's Perspective in 2019.结肠癌:2019年临床医生的视角
Gastroenterology Res. 2020 Feb;13(1):1-10. doi: 10.14740/gr1239. Epub 2020 Feb 1.
9
Circulating molecular biomarkers for screening or early diagnosis of colorectal cancer: which is ready for prime time?用于结直肠癌筛查或早期诊断的循环分子生物标志物:哪种已准备好进入黄金时代?
Ann Transl Med. 2019 Nov;7(21):610. doi: 10.21037/atm.2019.08.97.
10
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.